Consensus on the tertiary prevention of primary liver cancer Yuemin NanXiaoyuan XuChinese Society of Hepatology, Chinese Medical Association Consensus Open access 27 June 2023 Pages: 1057 - 1071
HBV prophylaxis after liver transplantation: close to the full success but at the price of long-term prophylaxis adapted to the risk of HBV recurrence Bruno RocheDidier Samuel Editorial 23 June 2023 Pages: 1072 - 1074
Targeting immuno-metabolism and anti-viral immune responses in chronic hepatitis B Suzanne Faure-DupuyThomas F. Baumert Editorial 27 June 2023 Pages: 1075 - 1078
Prospects for treatment of esophageal varices considering the safety of endoscopic band ligation Tomohiro KatsumiYoshiyuki Ueno Editorial 08 July 2023 Pages: 1079 - 1081
Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes Karl VazDaniel Clayton-ChubbStuart K. Roberts Review Article Open access 09 August 2023 Pages: 1082 - 1097
Management of adults with Alagille syndrome Mohammed D. AyoubAhmad A. BakhshBinita M. Kamath Review Article Open access 16 August 2023 Pages: 1098 - 1112
High-potency nucleos(t)ide analogues alone or plus immunoglobulin for HBV prophylaxis after liver transplantation: a meta-analysis Li-Ping ShengJun-Chang ZhangGui-Qiang Wang Original Article 02 January 2023 Pages: 1113 - 1124
Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis B Yu-Long FuShuang-Nan ZhouChao Zhang Original Article Open access 28 March 2023 Pages: 1125 - 1138
Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B Shang-Chin HuangTung-Hung SuJia-Horng Kao Original Article 29 May 2023 Pages: 1139 - 1149
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study Yu Jun WongSally TranMindie H. Nguyen Original Article 05 June 2023 Pages: 1150 - 1161
Liver fibrosis quantified by image morphometry predicts clinical outcomes in patients with non-alcoholic fatty liver disease Zhengyi WangGary P. JeffreyLeon A. Adams Original Article Open access 26 June 2023 Pages: 1162 - 1169
Exosome GLUT1 derived from hepatocyte identifies the risk of non-alcoholic steatohepatitis and fibrosis Wenyan ZhangJing ZhangHongbo Shi Original Article 06 June 2023 Pages: 1170 - 1181
A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort study Jiarong XieLei XuChengfu Xu Original Article 15 June 2023 Pages: 1182 - 1191
Association of nonmalignant portal vein thrombosis and clinical outcomes in patients with cirrhosis and acute variceal bleeding: a multicenter observational study Yong LvWei BaiGuohong Han Original Article 31 May 2023 Pages: 1192 - 1204
Endoscopic band ligation is safe despite low platelet count and high INR Nikolaus PfistererMichael SchwarzThomas Reiberger Original Article Open access 06 April 2023 Pages: 1205 - 1214
Oxidative stress-related markers as prognostic factors for patients with primary sclerosing cholangitis in Japan Atsushi OyamaAkinobu TakakiMotoyuki Otsuka Original Article Open access 26 July 2023 Pages: 1215 - 1224
Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure Serami MurakamiMichio ImamuraShiro Oka Original Article 26 April 2023 Pages: 1225 - 1232
Healthcare utilization and outcomes of living donor liver transplantation for patients with APASL-defined acute-on-chronic liver failure Anand V. KulkarniRaghuram ReddyK. Rajender Reddy Original Article 05 June 2023 Pages: 1233 - 1240
Mixed mode of artificial liver support in patients with acute-on-chronic liver failure: a retrospective cohort study Xiao-hao WangBin-bin PengShan Zhong Original Article 07 August 2023 Pages: 1241 - 1250
Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched study Shi-Ye YangJin-Kai FengWei-Xing Guo Original Article 15 April 2023 Pages: 1251 - 1264
Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1 Jie HuWei-Feng LiuJian Zhou Original Article 28 April 2023 Pages: 1265 - 1278
Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy? Renguo GuanJie MeiRongping Guo Original Article 02 May 2023 Pages: 1279 - 1288
Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinoma Issei SaekiYutaka SuehiroTakahiro Yamasaki Original Article 25 April 2023 Pages: 1289 - 1299
Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes Zimin SongShuirong LinShunli Shen Original Article Open access 27 June 2023 Pages: 1300 - 1317
Fecal microbiota transplantation in alcoholic hepatitis: new treatment paradigm or a shot in the dark? Prajna AnirvanManas Kumar PanigrahiShivaram Prasad Singh Letter to the Editor 24 April 2023 Pages: 1318 - 1319
Reply to: “developing real‑world prognostic models for patients with advanced hepatocellular carcinoma: CRAFITY, mALF and beyond” Takeshi HatanakaSatoru KakizakiTakashi Kumada Letter to the Editor 03 June 2023 Pages: 1320 - 1321
Response to: “Is laparoscopic hepatectomy superior to laparotomic hepatectomy? The debate continues” Shi-Ye YangJin-Kai FengWei-Xing Guo Letter to the Editor 04 March 2023 Pages: 1322 - 1323
HBV, antivirals, and immunoglobulins after liver transplantation: all that glitters is not gold Edoardo G. GianniniQuirino Lai Letter to the Editor 02 March 2023 Pages: 1324 - 1325
Correction to: Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure Serami MurakamiMichio ImamuraShiro Oka Correction 12 June 2023 Pages: 1326 - 1326